Exploring the Rationale, Results, and Real-World Clinical Potential of BTKi in the Management of MS

Co-Chairs, Anne H. Cross, MD, FAAN, and Prof. Xavier Montalban, discuss multiple sclerosis in this CME/NCPD/CPE activity titled “ Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis.” For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/BTV865. CME/NCPD/CPE credit will be available until January 31, 2022.

Видео Exploring the Rationale, Results, and Real-World Clinical Potential of BTKi in the Management of MS канала PeerView CME